blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1932835

EP1932835 - METHOD FOR PRODUCING 2,3-DIHYDROPYRIDAZINE COMPOUND [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  31.10.2014
Database last updated on 13.09.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR
published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Sumitomo Chemical Company, Limited
27-1, Shinkawa 2-chome, Chuo-ku
Tokyo 104-8260 / JP
[2008/25]
Inventor(s)01 / SASAKI, Kazuaki
13-32, Hoshimi-cho
Ibaraki-shi, Osaka 567-0843 / JP
 [2008/25]
Representative(s)Duckworth, Timothy John, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[2014/15]
Former [2013/52]Benson, John Everett, et al
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2010/26]Benson, John Everett, et al
J. A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Former [2008/29]Cresswell, Thomas Anthony
J.A. KEMP & CO. 14 South Square Gray's Inn London
WC1R 5JJ / GB
Former [2008/25]Cresswell, Thomas Anthony
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date06796833.922.08.2006
[2008/25]
WO2006JP316797
Priority number, dateJP2005024884430.08.2005         Original published format: JP 2005248844
[2008/25]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007026624
Date:08.03.2007
Language:JA
[2007/10]
Type: A1 Application with search report 
No.:EP1932835
Date:18.06.2008
Language:EN
[2008/25]
Type: B1 Patent specification 
No.:EP1932835
Date:25.12.2013
Language:EN
[2013/52]
Search report(s)International search report - published on:JP08.03.2007
(Supplementary) European search report - dispatched on:EP30.03.2010
ClassificationIPC:C07D237/20
[2008/25]
CPC:
C07D237/20 (EP,KR,US); A61P33/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/25]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER 2,3-DIHYDROPYRIDAZINVERBINDUNG[2008/25]
English:METHOD FOR PRODUCING 2,3-DIHYDROPYRIDAZINE COMPOUND[2008/25]
French:PROCÉDÉ DE PRODUCTION D'UN COMPOSÉ 2,3-DIHYDROPYRIDAZINE[2008/25]
Entry into regional phase18.03.2008Translation filed 
18.03.2008National basic fee paid 
18.03.2008Search fee paid 
18.03.2008Designation fee(s) paid 
18.03.2008Examination fee paid 
Examination procedure18.03.2008Examination requested  [2008/25]
07.07.2010Despatch of a communication from the examining division (Time limit: M06)
14.01.2011Reply to a communication from the examining division
07.10.2011Despatch of a communication from the examining division (Time limit: M04)
14.02.2012Reply to a communication from the examining division
12.08.2013Communication of intention to grant the patent
14.11.2013Fee for grant paid
14.11.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.07.2010
Opposition(s)26.09.2014No opposition filed within time limit [2014/49]
Fees paidRenewal fee
14.08.2008Renewal fee patent year 03
12.08.2009Renewal fee patent year 04
17.08.2010Renewal fee patent year 05
11.08.2011Renewal fee patent year 06
10.08.2012Renewal fee patent year 07
19.08.2013Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.12.2013
BE25.12.2013
BG25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SI25.12.2013
SK25.12.2013
TR25.12.2013
GR26.03.2014
IS25.04.2014
PT28.04.2014
IE22.08.2014
LU22.08.2014
[2016/33]
Former [2016/28]AT25.12.2013
BE25.12.2013
BG25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SI25.12.2013
SK25.12.2013
GR26.03.2014
IS25.04.2014
PT28.04.2014
IE22.08.2014
LU22.08.2014
Former [2016/25]AT25.12.2013
BE25.12.2013
BG25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SI25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
IE22.08.2014
LU22.08.2014
Former [2015/37]AT25.12.2013
BE25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SI25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
IE22.08.2014
LU22.08.2014
Former [2015/24]AT25.12.2013
BE25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SI25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
LU22.08.2014
Former [2015/19]AT25.12.2013
BE25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
LU22.08.2014
Former [2015/18]AT25.12.2013
BE25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
MC25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
Former [2014/39]AT25.12.2013
BE25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
NL25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
Former [2014/37]AT25.12.2013
BE25.12.2013
CY25.12.2013
CZ25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
PL25.12.2013
RO25.12.2013
SE25.12.2013
SK25.12.2013
IS25.04.2014
PT28.04.2014
Former [2014/36]BE25.12.2013
EE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
SE25.12.2013
IS25.04.2014
Former [2014/34]BE25.12.2013
FI25.12.2013
LT25.12.2013
LV25.12.2013
SE25.12.2013
Former [2014/25]FI25.12.2013
LT25.12.2013
LV25.12.2013
SE25.12.2013
Former [2014/22]FI25.12.2013
LT25.12.2013
SE25.12.2013
Former [2014/20]LT25.12.2013
Documents cited:Search[Y]DE414146  (FRITZ REINDEL DR) [Y] 1-8* page 1, left column, lines 25-35 *;
 [Y]DE451733  (A E TSCHITSCHIBABIN DR) [Y] 1-8 * page 2, right column, lines 102-116 *;
 [Y]  - JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS 200505 GB, (200505), vol. 48, no. 6, ISSN 0362-4803, pages 397 - 406, XP002573779 [Y] 1-8 * compound 2, page 398 and page 400-401 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.